The effects of premium intraocular lenses on presbyopia treatments.

Yanan Zhu, Yueyang Zhong, Yanyan Fu
Author Information
  1. Yanan Zhu: Eye Center of the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, Zhejiang Province, China.
  2. Yueyang Zhong: Eye Center of the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, Zhejiang Province, China.
  3. Yanyan Fu: Eye Center of the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, Zhejiang Province, China.

Abstract

Background: Presbyopia has become a global disease affecting the world's aging population. Among various treatments, cataract extraction and intraocular lens (IOL) implantation have become the most popular and common methods of presbyopia correction. During the twentieth century, IOLs have underwent significant innovation and advancements to meet the patients' high demands for functional vision at all distances.
Main Text: To meet the increasing needs for excellent near and intermediate vision for daily activities, some premium IOLs with more than one focus have been developed, for example, the refractive MfIOLs, diffractive MfIOLs, extended depth of field (EDOF) IOLs, and accommodating IOLs (AIOLs) were introduced to meet this need. In addition, the add-on MfIOLs have been explored as promising supplementary IOLs for pseudophakic presbyopia. When selecting the MfIOLs, the IOLs' features, patients' characteristics, preoperative eye conditions, and treatment expectations should be considered.
Conclusions: In this review, we focus on the multifocal IOLs (MfIOLs) commonly used for presbyopia correction and systematically summarized their optical designs and clinical outcomes. More evidence-based studies are required to provide guidelines for MfIOL selection, provide maximum visual benefits, and develop personalized visual solutions in the future.

Keywords

References

  1. Clin Exp Optom. 2020 Jan;103(1):21-30 [PMID: 31734940]
  2. Cochrane Database Syst Rev. 2020 Jun 18;6:CD012648 [PMID: 32584432]
  3. J Cataract Refract Surg. 2014 Feb;40(2):313-22 [PMID: 24461503]
  4. Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6100-4 [PMID: 16597675]
  5. J Refract Surg. 2018 Aug 1;34(8):507-514 [PMID: 30089179]
  6. Ophthalmic Res. 2021;64(3):503-511 [PMID: 33326968]
  7. Am J Ophthalmol. 2014 Sep;158(3):436-46.e1 [PMID: 24932989]
  8. Turk J Med Sci. 2016 Apr 19;46(3):597-603 [PMID: 27513232]
  9. J Biomed Opt. 2012 Apr;17(4):046013 [PMID: 22559691]
  10. Am J Ophthalmol. 2017 Dec;184:52-62 [PMID: 28923587]
  11. J Cataract Refract Surg. 2016 Dec;42(12):1721-1729 [PMID: 28007103]
  12. Prog Retin Eye Res. 2019 Jan;68:124-143 [PMID: 30244049]
  13. J Cataract Refract Surg. 2010 Aug;36(8):1323-9 [PMID: 20656155]
  14. J Ophthalmol. 2018 Jun 25;2018:8285637 [PMID: 30046464]
  15. J Refract Surg. 2016 Nov 1;32(11):742-747 [PMID: 27824377]
  16. PLoS One. 2019 Feb 4;14(2):e0211823 [PMID: 30716136]
  17. Eur J Ophthalmol. 2021 Sep;31(5):2346-2352 [PMID: 33158370]
  18. J Cataract Refract Surg. 2014 Dec;40(12):2113-9 [PMID: 25465689]
  19. Eur J Ophthalmol. 2019 Jul;29(4):417-425 [PMID: 30198329]
  20. J Cataract Refract Surg. 2004 Dec;30(12):2494-503 [PMID: 15617915]
  21. Ophthalmology. 2021 Nov;128(11):e74-e93 [PMID: 32619547]
  22. J Cataract Refract Surg. 2004 Dec;30(12):2483-93 [PMID: 15617914]
  23. Graefes Arch Clin Exp Ophthalmol. 2019 Mar;257(3):575-582 [PMID: 30701319]
  24. J Cataract Refract Surg. 2009 Oct;35(10):1671-8 [PMID: 19781458]
  25. Graefes Arch Clin Exp Ophthalmol. 2010 Jan;248(1):133-40 [PMID: 19763600]
  26. Curr Opin Ophthalmol. 2018 Jul;29(4):318-322 [PMID: 29697436]
  27. J Cataract Refract Surg. 2013 Feb;39(2):268-78 [PMID: 23332253]
  28. Sci Rep. 2020 Sep 9;10(1):14832 [PMID: 32908159]
  29. Ophthalmol Ther. 2021 Mar;10(1):101-113 [PMID: 33245545]
  30. J Cataract Refract Surg. 2017 Aug;43(8):1020-1026 [PMID: 28917400]
  31. Med Hypothesis Discov Innov Ophthalmol. 2012 Spring;1(1):3-5 [PMID: 24600609]
  32. Asia Pac J Ophthalmol (Phila). 2019 Jul-Aug;8(4):335-349 [PMID: 31403494]
  33. J Cataract Refract Surg. 2016 Sep;42(9):1268-1275 [PMID: 27697244]
  34. Clin Ophthalmol. 2013;7:1957-65 [PMID: 24124348]
  35. Transl Vis Sci Technol. 2020 Mar 09;9(4):6 [PMID: 32818094]
  36. Curr Opin Ophthalmol. 2017 Jan;28(1):3-8 [PMID: 27653608]
  37. Ophthalmology. 2017 Feb;124(2):P1-P119 [PMID: 27745902]
  38. J Cataract Refract Surg. 2007 Nov;33(11):1913-7 [PMID: 17964397]
  39. BMC Ophthalmol. 2019 Aug 28;19(1):197 [PMID: 31462225]
  40. J Cataract Refract Surg. 2015 Oct;41(10):2107-14 [PMID: 26703286]
  41. J Cataract Refract Surg. 2012 May;38(5):765-73 [PMID: 22520302]
  42. Jpn J Ophthalmol. 2019 Nov;63(6):429-436 [PMID: 31641897]
  43. Int J Ophthalmol. 2018 Jun 18;11(6):1028-1037 [PMID: 29977819]
  44. Eur J Ophthalmol. 2018 Jul;28(4):425-432 [PMID: 29623732]
  45. Clin Ophthalmol. 2014 Nov 19;8:2289-95 [PMID: 25429198]
  46. Asia Pac J Ophthalmol (Phila). 2020 May-Jun;9(3):194-202 [PMID: 32511121]
  47. Int Ophthalmol. 2020 Feb;40(2):393-401 [PMID: 31624988]
  48. Curr Opin Ophthalmol. 2017 Jan;28(1):9-15 [PMID: 27828894]
  49. Eye Contact Lens. 2015 Sep;41(5):323-7 [PMID: 25806674]
  50. Ophthalmology. 2008 Sep;115(9):1508-16 [PMID: 18538402]
  51. Ophthalmology. 2021 Feb;128(2):197-207 [PMID: 33004211]
  52. Ophthalmic Physiol Opt. 2014 Jan;34(1):8-29 [PMID: 24205890]
  53. Am J Ophthalmol. 2015 Oct;160(4):702-9.e1 [PMID: 26209232]
  54. J Cataract Refract Surg. 2015 Jul;41(7):1490-502 [PMID: 26287887]
  55. J Refract Surg. 2019 Jul 1;35(7):418-425 [PMID: 31298721]
  56. Curr Opin Ophthalmol. 2005 Feb;16(1):8-26 [PMID: 15650575]
  57. J Cataract Refract Surg. 2012 Sep;38(9):1568-75 [PMID: 22906443]
  58. J Ophthalmol. 2014;2014:458296 [PMID: 25505974]
  59. Ophthalmol Ther. 2021 Dec;10(4):1093-1104 [PMID: 34689301]
  60. Ophthalmic Physiol Opt. 2016 Jan;36(1):1-4 [PMID: 26769325]
  61. J Cataract Refract Surg. 2011 Nov;37(11):2043-52 [PMID: 22018366]
  62. J Am Geriatr Soc. 2002 Nov;50(11):1760-6 [PMID: 12410892]
  63. J Cataract Refract Surg. 2007 Feb;33(2):197-202 [PMID: 17276258]
  64. J Nippon Med Sch. 2021 Nov 17;88(5):398-407 [PMID: 32999178]
  65. J Cataract Refract Surg. 2013 Mar;39(3):350-7 [PMID: 23290317]
  66. Curr Opin Ophthalmol. 2018 Jul;29(4):313-317 [PMID: 29708928]
  67. J Physiol. 2018 Jan 15;596(2):253-266 [PMID: 29071723]
  68. J Cataract Refract Surg. 2009 Jun;35(6):992-7 [PMID: 19465282]
  69. J Cataract Refract Surg. 2016 Jun;42(6):920-30 [PMID: 27373400]
  70. J Cataract Refract Surg. 2007 Nov;33(11):1930-5 [PMID: 17964400]
  71. Int Ophthalmol. 2021 Feb;41(2):567-573 [PMID: 33040273]
  72. J Cataract Refract Surg. 2011 Feb;37(2):241-50 [PMID: 21241905]
  73. J Refract Surg. 2020 Sep 1;36(9):578-584 [PMID: 32901824]
  74. J Refract Surg. 2014 Jan;30(1):41-8 [PMID: 24864327]
  75. J Cataract Refract Surg. 2018 Feb;44(2):156-167 [PMID: 29587972]
  76. Am J Ophthalmol. 2016 Apr;164:37-48 [PMID: 26829595]
  77. J Cataract Refract Surg. 2010 Apr;36(4):603-8 [PMID: 20362852]
  78. Transl Vis Sci Technol. 2020 Feb 12;9(3):6 [PMID: 32704426]
  79. Eur J Ophthalmol. 2012 May-Jun;22(3):356-62 [PMID: 21928262]
  80. Ophthalmology. 2002 Nov;109(11):1970-6; discussion 1976-7 [PMID: 12414400]
  81. Curr Opin Ophthalmol. 2004 Aug;15(4):365-9 [PMID: 15232478]
  82. J Cataract Refract Surg. 2011 Nov;37(11):2060-7 [PMID: 22018368]
  83. J Cataract Refract Surg. 2016 Oct;42(10):1415-1423 [PMID: 27839595]
  84. Ophthalmology. 2015 Apr;122(4):700-10 [PMID: 25537197]
  85. J Cataract Refract Surg. 2011 Jan;37(1):27-37 [PMID: 21183097]
  86. Eye (Lond). 2019 Mar;33(3):404-410 [PMID: 30266985]
  87. Open Ophthalmol J. 2015 Jan 30;9:1-7 [PMID: 25674189]
  88. BMC Ophthalmol. 2017 Feb 14;17(1):12 [PMID: 28196497]
  89. Clin Ophthalmol. 2020 Apr 09;14:1043-1054 [PMID: 32308364]
  90. Surv Ophthalmol. 1996 Jan-Feb;40(4):279-92 [PMID: 8658339]
  91. Ophthalmology. 2021 Nov;128(11):e164-e185 [PMID: 32980397]
  92. J Cataract Refract Surg. 2020 Feb;46(2):193-203 [PMID: 32126031]
  93. J Cataract Refract Surg. 2010 Sep;36(9):1508-16 [PMID: 20692563]
  94. Br J Ophthalmol. 2015 Dec;99(12):1655-9 [PMID: 25987651]
  95. Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):341-8 [PMID: 22588290]
  96. J Ophthalmic Vis Res. 2015 Oct-Dec;10(4):370-4 [PMID: 27051480]
  97. Ophthalmology. 2007 Nov;114(11):2038-43 [PMID: 17555820]
  98. Adv Ophthalmol Pract Res. 2021 Oct 21;1(1):100008 [PMID: 37846393]
  99. Surv Ophthalmol. 2017 Sep - Oct;62(5):611-634 [PMID: 28366683]
  100. Jpn J Ophthalmol. 2017 Mar;61(2):142-149 [PMID: 28091897]

Word Cloud

Created with Highcharts 10.0.0intraocularlensIOLsMfIOLspresbyopiameetPresbyopiabecometreatmentscorrectionpatients'visionpremiumfocusdepthfieldoutcomesprovidevisualBackground:globaldiseaseaffectingworld'sagingpopulationAmongvariouscataractextractionIOLimplantationpopularcommonmethodstwentiethcenturyunderwentsignificantinnovationadvancementshighdemandsfunctionaldistancesMainText:increasingneedsexcellentnearintermediatedailyactivitiesonedevelopedexamplerefractivediffractiveextendedEDOFaccommodatingAIOLsintroducedneedadditionadd-onexploredpromisingsupplementarypseudophakicselectingIOLs'featurescharacteristicspreoperativeeyeconditionstreatmentexpectationsconsideredConclusions:reviewmultifocalcommonlyusedsystematicallysummarizedopticaldesignsclinicalevidence-basedstudiesrequiredguidelinesMfIOLselectionmaximumbenefitsdeveloppersonalizedsolutionsfutureeffectslensesAccommodatingClinicalExtendedIntraocularMonofocalMultifocal

Similar Articles

Cited By (2)